Results 1 to 10 of about 1,805,472 (279)
Epilepsy-Related Direct Medical and Direct Non-Medical Cost in Adult Patients Living with Epilepsy at a Tertiary Neurology Center in Rwanda. [PDF]
Dirk E Teuwen,1,2 Fidele Sebera,1,3,4 Alphonsine Murekeyiteto,5 Ieme Garrez,1,2 Eduardo Sanchez-Iriso,6 Josiane Umwiringirwa,3 Georgette Umuhoza,3 Paul AJM Boon,1,2 Peter Dedeken1,2,7 1Department of Neurology, Ghent University Hospital, Ghent, Belgium; 2
Teuwen DE +8 more
europepmc +3 more sources
ObjectiveThis study was conducted to estimate the direct non-medical cost of advanced non-small cell lung cancer (NSCLC) patients and explore whether its associated factors vary by health status.MethodsData were obtained from 13 centers in five provinces
Yu Xia +11 more
doaj +2 more sources
Background: Heart failure (HF) is considered a significant public health issue with a substantial and growing epidemiologic and economic burden in relation to longer life expectancy and aging global population Aims: To determine cost-of-disease of heart
Yüksel Çavuşoğlu +10 more
doaj +2 more sources
Productivity losses and treatment cost of benign prostatic hyperplasia in Ghana. [PDF]
Benign Prostatic Hyperplasia (BPH) is a common condition among ageing men, characterized by lower urinary tract symptoms that significantly impact the quality of life and economic productivity of affected individuals.
Dadee-Seshie DS +7 more
europepmc +2 more sources
Estimation of direct and indirect costs associated with obesity treatment interventions among adult populations in Iran. [PDF]
Background The prevalence of obesity worldwide has reached pandemic levels and is anticipated to escalate swiftly in developing nations. Given the substantial surge in obesity rates observed over the last three decades, assessing obesity-related costs is
Sharif FV +3 more
europepmc +2 more sources
Quantifying the direct costs of diabetic retinopathy in a mixed healthcare system: a hospital-based study from governmental and patient perspectives. [PDF]
Background Advanced diabetic retinopathy (DR), including proliferative DR and diabetic macular edema (DME), demands costly interventions like anti-VEGF therapy, laser treatment, and vitrectomy.
Jabbar RM, Al-Jumaili AA, Jaafar AD.
europepmc +2 more sources
Cost of Illness Type 2 Diabetes Mellitus Outpatient BPJS on Malang City Health Center
Background: Type 2 diabetes mellitus is a progressive illness that impacts the costs borne by patients. The Cost of Illness method can be used further to analyze the medical expenses for type 2 diabetes mellitus.
Ika Ratna Hidayati +2 more
doaj +1 more source
The economic cost of cancer treatment in Iran
BACKGROUND: With more than 12 million new cases of cancers and nearly 7.6 million deaths worldwide in 2020, cancer is currently the third leading cause of mortality in the world.
Alireza Jabbari +3 more
doaj +1 more source
The Cost of Von Willebrand Disease in Europe: The CVESS Study
Background Von Willebrand disease (VWD) is one of the most common inherited bleeding disorders, imposing a substantial health impact and financial burden.
George Morgan MSc +5 more
doaj +1 more source
Background Out-of-pocket expenditure constitutes high proportion of healthcare spending in low-income countries. It can affect patients’ adherence to treatments leading to serious health consequences.
Fitsum Sebsibe Teni +7 more
doaj +1 more source

